GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Total Operating Expense

ANRO (Alto Neuroscience) Total Operating Expense : $68.61 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Total Operating Expense?

Alto Neuroscience's Total Operating Expense for the three months ended in Dec. 2024 was $17.00 Mil. Alto Neuroscience's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $68.61 Mil.

Alto Neuroscience Total Operating Expense Historical Data

The historical data trend for Alto Neuroscience's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Total Operating Expense Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Operating Expense
9.29 27.46 37.81 68.61

Alto Neuroscience Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.77 14.39 18.34 18.89 17.00

Alto Neuroscience Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $68.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Total Operating Expense
Comparable Companies
IOBT INZY VTGN CBUS CABA BYSI VANI CLSD MGX PYXS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
650 Castro Street, Suite 450, Mountain View, CA, USA, 94041
Website
https://www.altoneuroscience.com
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.